© Borgis - New Medicine 3/2009, s. 51-52
*Ewa Ogłodek1, Danuta Mo?2, Aleksander Araszkiewicz1, Waldemar Placek3
Sense of alexithymia in a patient with vitiligo and paranoid schizophrenia
1Chair and Clinic of Psychiatry of the Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poland
2Individual medical practice
3Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology of the Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poland
Summary
Aim.The behaviour contemporarily known as alexithymia was first described in detail by psychiatrists Peter E. Sifneos and John C. Nemiah. Over the past few decades the concept of alexithymia has been refined theoretically, and it is presently defined by the following features: (1) difficulty in identifying feelings and distinguishing between feelings and bodily sensations of emotional arousal; (2) difficulty in describing feelings to other people; (3) constricted imaginal processes, as evidenced by a paucity of fantasies; and (4) a stimulus-bound, externally oriented cognitive style.
The aim of the research was to evaluate the sense of alexithymia in a female patient with vitiligo and paranoid schizophrenia.
Material and Method. DSM-IV classification was used in the psychiatric examination of the patient in question and paranoid schizophrenia was diagnosed. This was followed by examining the patient by means of the shortened version of the Toronto Alexithymia Scale (TAS-20). The scale is characterized by high discrimination power, internal coherence and reliability.
Results. An analysis of the TAS-20 scale results revealed the highest value of the "difficulties identifying feelings” factor.
Conclusions. Sense of alexithymia may be a result of long-term stress which, in turn, leads to the development of vitiligo and paranoid schizophrenia.
Introduction
Sense of alexithymia is a term which was first proposed by Sifenos to describe disorders related to a patient´s expression and perception of his/her own feelings. Alexithymia is a concept that has been receiving increasing attention in psychosomatic research. The alexithymia construct involves „difficulty in identifying and describing feelings and difficulty in distinguishing between feelings and the bodily sensations of emotional arousal”. Limited abilities of a patient with vitiligo and sense of alexithymia to experience emotions cognitively lead to the patient´s concentration on somatic sensations. This is accompanied by emotional excitement and by poorly controlled compulsive reactions to negative stimulation. Sense of alexithymia in patients with paranoid schizophrenia and vitiligo is treated as a personality trait which, in combination with other features, predisposes a patient to emotional disturbances.
Vitiligo is a disease characterized clinically by the sudden appearance of sharply demarcated patches of milk white skin. This is a chronic, progressive disease in which depigmentation results in extreme alterations in appearance and intense psychological distress for the patient [1].
Aim
The aim of the research was to evaluate the sense of alexithymia in a female patient with vitiligo and paranoid schizophrenia.
MATERIAL AND Method
12 patients with schizophrenia and vitiligo were included in the study (average age 34.20 ± 5.3 years). The patients were under the care of the Chair and Clinic of Dermatology, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. A control group consisted of 12 mentally healthy persons (average age 34.20 ± 5.3 years). Both the study group and the control group included 6 men and 6 women.
Patients with paranoid schizophrenia and vitiligo were tested for sense of alexithymia by the shortened version of the Toronto Alexithymia Scale (TAS-20). Patients in the control group were tested in the same way.
The Toronto Alexithymia Scale is a 20-item Likert scale to measure alexithymia. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree. The TAS-20 uses cut-off scoring: equal to or less than 51 = non-alexithymia, equal to or greater than 61 = alexithymia. Scores of 52 to 60 = possible alexithymia.
The scale is characterized by high discrimination power, internal coherence and reliability.
Results
In the research a DSM-IV classification was used in the psychiatric examination of the patients with paranoid schizophrenia. The patients had remission of the disease for at least 2 years. In the study and control group the TAS-20 scale was used to measure the following 3 factors of alexithymia: F-1: difficulties in identifying feelings, F-2: difficulties in describing feelings, and F-3: externally oriented thinking. The measurements conducted in the study group were compared to the control group. The total score of TAS-20 in patients with paranoid schizophrenia and vitiligo was 70. The analysis of the TAS-20 scale results in this group revealed the highest value of the "difficulties in identifying feelings” factor. The control group did not show features of alexithymia; the total score was 25. Fig. 1 presents the percentage distribution of particular alexithymia factors in patients with paranoid schizophrenia and vitiligo.
Fig. 1. TAS-20 scale in patients with paranoid schizophrenia and vitiligo.
Discussion
Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
- Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
- Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
- Aby kupić kod proszę skorzystać z jednej z poniższych opcji.
Opcja #1
19 zł
Wybieram
- dostęp do tego artykułu
- dostęp na 7 dni
uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony
Opcja #2
49 zł
Wybieram
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 30 dni
- najpopularniejsza opcja
Opcja #3
119 zł
Wybieram
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 90 dni
- oszczędzasz 28 zł
Piśmiennictwo
1. Cedro A et al.: Alexithymia in schizophrenia: an exploratory study. Psychol Rep. 2001; 89(1): 95-8. 2. Bagby RM et al.: The twenty-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994; 38(1): 23–32. 3. Ongenae K et al.: Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005; 152(6): 1165-72. 4. Picardi A et al.: Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom. 2003; 72(3): 150-8. 5. Koshevenko I: The psychological characteristics of patients with vitiligo. Vestn Dermatol Venerol. 1989; (5): 4-6. 6. Maggini C et al.: Alexithymia and schizophrenic psychopathology. Acta Biomed. 2004; 75(1): 40-9. 7. Sampogna F et al.: Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008; 159(2): 351-9. 8. Spitzer C et al.: Alexithymia and interpersonal problems. Psychother Psychosom. 2005; 74(4): 240-6. 9. Todarello O et al.: Is Alexithymia related to negative symptoms of schizophrenia? Psychopathology. 2005; 38(6): 310-4. 10. Willemsen R et al.: Alexithymia and dermatology: the state of the art. Int J Dermatol. 2008; 47(9): 903-10.
